NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

NCT05522556

AvailableN/A

Sponsor: Pfizer

Conditions: Alopecia Areata

Interventions: Ritlecitinib

Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.

Eligibility overview

Sex: ALL

Age: 12 Years to —

Study type: EXPANDED_ACCESS

Eligibility criteria

Must have ≥ 50% hair loss on scalp due to Alopecia Areata (AA) and be intolerant or have inadequate response to all commonly used AA therapies accessible in the country. Additional eligibility criteria may be required.